CATALOGO DEI PRODOTTI DELLA RICERCA

PERTILE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.689
NA - Nord America 2.324
AS - Asia 1.423
SA - Sud America 203
AF - Africa 37
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.683
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.282
RU - Federazione Russa 949
SG - Singapore 587
GB - Regno Unito 529
IT - Italia 457
CN - Cina 451
BR - Brasile 176
HK - Hong Kong 156
DE - Germania 150
FR - Francia 148
IE - Irlanda 119
SE - Svezia 118
FI - Finlandia 95
VN - Vietnam 76
KR - Corea 33
UA - Ucraina 26
CA - Canada 25
IN - India 20
NL - Olanda 16
BD - Bangladesh 15
BE - Belgio 14
ES - Italia 14
PL - Polonia 14
JP - Giappone 13
TR - Turchia 12
ID - Indonesia 11
EC - Ecuador 10
TG - Togo 9
IQ - Iraq 8
PT - Portogallo 8
MX - Messico 7
SA - Arabia Saudita 7
AR - Argentina 6
AT - Austria 6
BJ - Benin 6
CZ - Repubblica Ceca 6
ZA - Sudafrica 6
AU - Australia 5
EG - Egitto 5
GR - Grecia 5
IR - Iran 5
CO - Colombia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
JO - Giordania 3
KZ - Kazakistan 3
MA - Marocco 3
SY - Repubblica araba siriana 3
UG - Uganda 3
AZ - Azerbaigian 2
BH - Bahrain 2
CH - Svizzera 2
CL - Cile 2
JM - Giamaica 2
LT - Lituania 2
MY - Malesia 2
PY - Paraguay 2
TH - Thailandia 2
TW - Taiwan 2
AO - Angola 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MT - Malta 1
NC - Nuova Caledonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
Totale 6.683
Salva come PNG Salva come JPEG
Città #
Southend 437
Dallas 317
Moscow 310
Chandler 308
Singapore 295
Woodbridge 198
Ashburn 186
Ann Arbor 166
Jacksonville 163
Hong Kong 151
Dublin 113
Verona 103
Beijing 64
Padova 56
Los Angeles 50
Milan 46
Princeton 46
Lawrence 44
The Dalles 44
Munich 43
New York 41
Wilmington 41
Houston 39
Helsinki 33
Nanjing 31
Shenyang 28
Tianjin 26
Jinan 25
Buffalo 23
Ho Chi Minh City 23
São Paulo 21
Boardman 17
Zhengzhou 16
Hanoi 15
Brussels 14
Columbus 14
Guangzhou 14
Hebei 14
Lancaster 14
Montreal 14
Warsaw 14
London 13
Sindelfingen 13
Taiyuan 13
Redondo Beach 12
Santa Clara 12
Tokyo 12
Haikou 11
Hangzhou 11
Seattle 11
Chennai 10
Falkenstein 10
Ningbo 10
Phoenix 10
Stockholm 10
Council Bluffs 9
Jakarta 9
Jiaxing 9
Lomé 9
Norwalk 9
Redmond 9
Roverbella 9
San Francisco 9
Taizhou 9
Atlanta 8
Changsha 8
Denver 8
Orem 8
Afragola 7
Ankara 7
Chicago 7
Dong Ket 7
Frankfurt am Main 7
Meda 7
Nanchang 7
Poplar 7
Rome 7
Belluno 6
Belo Horizonte 6
Boston 6
Brooklyn 6
Cotonou 6
Lanzhou 6
Limena 6
Lonigo 6
Riyadh 6
Romola 6
San Jose 6
Venice 6
Washington 6
Ballyvaghan 5
Bari 5
Dearborn 5
Guayaquil 5
Issy-les-Moulineaux 5
Johannesburg 5
San Giovanni Lupatoto 5
Secaucus 5
Athens 4
Auburn Hills 4
Totale 4.077
Salva come PNG Salva come JPEG
Nome #
Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence 224
A Large Scale OLG Model for the Analysis of the Redistributive Effects of Policy Reforms 221
R&D and market size: who benefits from orphan drug regulation? 207
Public policies over the life cycle: a large scale OLG model for France, Italy and Sweden 193
Spillovers of Pharmaceutical Price Regulations: evidence from the AMNOG Reform in Germany 187
A large scale OLG model for France, Italy and Sweden: assessing the interpersonal and intrapersonal redistributive effects of public policies 184
Redistribution at the Local Level: The Case of Public Childcare in Italy. University of Verona Department of Economics Working Paper 21/2013 (ISSN 2036-2919) 165
Redistribution at the Local Level: The Case of Public Childcare in Italy 165
DRGs: the link between investment in technologies and appropriateness. WP Series University of Verona Department of Economics (ISSN 2036-2919), 31/2012 156
L'ISEE in Italia: una nota metodologica partendo dai dati EU-SILC. University of Verona Department of Economics Working Paper 6/2014 (ISSN 2036-2919) 154
Investimenti pubblici, risorse scarse: il ruolo dei diversi metodi di supporto alle decisioni 153
A Bayesian Decision-Theoretic Model of Sequential Experimentation with Delayed Response 153
Dynamic, economic approaches to HTA under uncertainty. WP Series University of Verona Department of Economics (ISSN 2036-2919), 03/2011 150
Drug Prices and Incentives to Innovation by the Pharmaceutical Industry 146
Job Sick Leave: Detecting Opportunistic Behavior 146
Public finance consolidation and fairness across living generations: the case of Italy. WP Series University of Verona Department of Economics (ISSN 2036-2919), 04/2012 143
The 2023 European Commission proposal and the 2024 European Parliament proposal for the EU pharmaceutical legislation: policy content analysis 141
A stepped-wedge randomised controlled trial to assess efficacy and cost-effectiveness of a care-bundle to prevent falls in older hospitalised patients 137
A Bayesian Decision-Theoretic Model of Sequential Experimentation with Delayed Response 136
Improving access to medicines and promoting pharmaceutical innovation 127
Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial 126
The dynamics of pharmaceutical regulation and R&D investments. WP Series University of Verona Department of Economics (ISSN 2036-2919), 4/2012 124
The timing of adoption of positron emission tomography:a real options approach 124
Efficienza e sostenibilità dell’intervento pubblico 122
A reply to "Who would benefit from average value-based pricing?" 122
Dynamic, incentive-compatible contracting for health services 122
An extension of the real option approach to the evaluation of health care technologies: the case of positron emission tomography 119
Investment in health technologies in a competitive model with real options 115
Optimal sequential sampling rules for the economic evaluation of health technologies 114
Two-part payments for the reimbursement of investments in health technologies 114
Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy 114
Late-Stage Pharmaceutical R&D and Pricing Policies under Two-Stage Regulation 114
Late-Stage Pharmaceutical R&D and Pricing Policies under Two-Stage Regulation 113
The dynamics of pharmaceutical regulation and R&D investments 113
Optimal Decision Rules for HTA Under Uncertainty: a Wider, Dynamic Perspective 112
Which valued-based price when patients are heterogeneous? 110
The fiscal disadvantage of young italians: a new view on consolidation and fairness 109
Cost-effective clinical trial design: Application of a Bayesian sequential model to the ProFHER pragmatic trial 109
Who should monitor job sick leave? 107
Strategic Interaction in Pharmaceutical Price Regulation: With or Without U? 106
The impact of managed entry agreements on pharmaceutical prices 106
Optimal Bayesian sequential sampling rules for the economic evaluation of health technologies 105
Pricing policies when patients are heterogeneous: a welfare analysis 104
Technology adoption, quality and health care costs: a review of the literature 103
R&D and market size: who benefits from orphan drug legislation? 101
Authors' Reply to Garattini and Freemantle: "Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition" 98
Static and dynamic effciency of irreversible health care investments under alternative payment rules 95
L’equità intergenerazionale delle politiche di bilancio 89
Static and Dynamic Efficiency of Irreversible Health Care investments under Alternative Payment Rules 86
Public health interventions: evaluating the economic evaluations 84
Valutare l’efficienza dei servizi ospedalieri in Italia: il caso delle aziende ospedaliero-universitarie 71
Optimal Sequential Sampling with Delayed Observations and Unknown Variance 67
Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition 58
Totale 6.764
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.121
article - articoli 11.300
book - libri 0
conference - conferenze 355
curatela - curatele 426
other - altro 8.471
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.569
Totale 44.242
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 32 6 18 40 13 26 19
2021/2022422 30 70 13 6 19 17 18 25 41 13 66 104
2022/2023804 60 96 72 122 76 194 7 53 84 12 24 4
2023/2024435 18 30 31 72 47 57 27 38 10 16 53 36
2024/20251.183 57 90 67 195 32 32 31 102 162 82 103 230
2025/20262.315 218 177 331 568 833 188 0 0 0 0 0 0
Totale 6.764